- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/56 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
Patent holdings for IPC class C07D 233/56
Total number of patents in this class: 206
10-year publication summary
|
19
|
22
|
23
|
25
|
7
|
10
|
7
|
11
|
4
|
3
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Gilead Sciences, Inc. | 2037 |
12 |
| BASF SE | 20915 |
8 |
| FUJIFILM Corporation | 29399 |
7 |
| Agency for Science, Technology and Research | 3626 |
5 |
| University of Maryland, Baltimore | 1020 |
5 |
| Bayer Cropscience AG | 2036 |
4 |
| Nippon Soda Co., Ltd. | 894 |
4 |
| sanofi-aventis | 366 |
4 |
| Janssen Pharmaceutica N.V. | 3383 |
3 |
| Alexion Pharmaceuticals, Inc. | 637 |
3 |
| NMD Pharma A/S | 38 |
3 |
| Sanofi | 4065 |
3 |
| Novartis AG | 10850 |
2 |
| Centre National de La Recherche Scientifique | 10432 |
2 |
| Murata Manufacturing Co., Ltd. | 24542 |
2 |
| Dow Technology Investments LLC | 270 |
2 |
| PRC-DeSoto International, Inc. | 577 |
2 |
| University of Florida Research Foundation, Inc. | 4026 |
2 |
| BioLab Sanus Farmaceutica Ltda. | 52 |
2 |
| Central Glass Company, Limited | 1267 |
2 |
| Other owners | 129 |